Investigating the safety and effectiveness of platelet-rich plasma with 5% minoxidil solution in the treatment of androgenic hair loss.

Phase 2

Recruiting

• Conditions: Androgenic hair loss.; Androgenic alopecia, unspecified; L64.9

• Registration Number: IRCT20110522006543N4
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 40

Inclusion Criteria

Men with hereditary hormonal hair loss
Age 18 years and above and less than 50 years
The rate of hair loss in patients in the form of Hamilton score 2 to 5 in men
Complete consent of the patient to participate in the plan

Exclusion Criteria

Having a hematological disorder
Iron deficiency anemia
Having coagulation disorders
Bone marrow aplasia
Suffering from sepsis
Having cancer

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Photography before and after treatment of the hair loss area. Timepoint: Before starting the intervention, each treatment session is monthly for 4 months and also 6 months after the end of the treatment. Method of measurement: Photography with a camera.;Safety. Timepoint: Before starting the intervention, each treatment session is monthly for 4 months and also 6 months after the end of the treatment. Method of measurement: Doctor's assessment of hair loss, history.;Efficacy. Timepoint: Before starting the intervention, each treatment session is monthly for 4 months and also 6 months after the end of the treatment. Method of measurement: Doctor's assessment of hair loss, patient's satisfaction, history.

Secondary Outcome Measures

Name	Time	Method
Side effects. Timepoint: At the beginning of the intervention, monthly for 4 months, once every month, after 6 months. Method of measurement: Observation.